Cargando…

STAT1 signaling shields T cells from NK cell-mediated cytotoxicity

The JAK-STAT pathway critically regulates T-cell differentiation, and STAT1 is postulated to regulate several immune-mediated diseases by inducing proinflammatory subsets. Here we show that STAT1 enables CD4(+) T-cell-mediated intestinal inflammation by protecting them from natural killer (NK) cell-...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Yu Hui, Biswas, Amlan, Field, Michael, Snapper, Scott B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385318/
https://www.ncbi.nlm.nih.gov/pubmed/30796216
http://dx.doi.org/10.1038/s41467-019-08743-8
Descripción
Sumario:The JAK-STAT pathway critically regulates T-cell differentiation, and STAT1 is postulated to regulate several immune-mediated diseases by inducing proinflammatory subsets. Here we show that STAT1 enables CD4(+) T-cell-mediated intestinal inflammation by protecting them from natural killer (NK) cell-mediated elimination. Stat1(−/−) T cells fail to expand and establish colitis in lymphopenic mice. This defect is not fully recapitulated by the combinatorial loss of type I and II IFN signaling. Mechanistically, Stat1(−/−) T cells have reduced expression of Nlrc5 and multiple MHC class I molecules that serve to protect cells from NK cell-mediated killing. Consequently, the depletion of NK cells significantly rescues the survival and spontaneous proliferation of Stat1(−/−) T cells, and restores their ability to induce colitis in adoptive transfer mouse models. Stat1(−/−) mice however have normal CD4(+) T cell numbers as innate STAT1 signaling is required for their elimination. Overall, our findings reveal a critical perspective on JAK-STAT1 signaling that might apply to multiple inflammatory diseases.